Aspira Pathlab & Diagnostics Ltd

₹ 140 1.54%

01 Oct 12:34 p.m.

About

Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services^[1]

Key Points

Business Overview:^[1]^[2]^[3]
Aspira Pathlab & Diagnostics Ltd (APDL) provides pathology and radiology investigation services through diagnostic centers in Mumbai. Serving B2B and B2C markets, the company offers diagnostic solutions to individual patients, hospitals, healthcare providers, and businesses.

Website BSE

Market Cap ₹ 144 Cr.
Current Price ₹ 140
High / Low ₹ 150 / 49.0
Stock P/E
Book Value ₹ 7.09
Dividend Yield 0.00 %
ROCE 2.84 %
ROE 0.69 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Debtor days have improved from 42.1 to 25.3 days.
Promoter holding has increased by 28.2% over last quarter.

Cons

Stock is trading at 20.0 times its book value
Company has low interest coverage ratio.
Company has a low return on equity of -2.59% over last 3 years.
Company might be capitalizing the interest cost
Earnings include an other income of Rs.0.53 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2.60	3.32	3.46	3.82	4.64	6.18	5.41	5.78	5.25	8.09	5.12	6.52	6.17
	2.92	3.68	3.83	3.95	4.29	4.83	4.65	4.73	4.44	5.90	6.33	6.85	5.83
Operating Profit	-0.32	-0.36	-0.37	-0.13	0.35	1.35	0.76	1.05	0.81	2.19	-1.21	-0.33	0.34
OPM %	-12.31%	-10.84%	-10.69%	-3.40%	7.54%	21.84%	14.05%	18.17%	15.43%	27.07%	-23.63%	-5.06%	5.51%
	0.10	0.14	0.10	0.08	0.09	0.08	0.09	0.13	0.11	0.14	0.13	0.14	0.12
Interest	0.10	0.10	0.09	0.08	0.08	0.08	0.09	0.09	0.09	0.10	0.10	0.10	0.09
Depreciation	0.39	0.39	0.38	0.38	0.38	0.36	0.39	0.37	0.37	0.40	0.38	0.40	0.41
Profit before tax	-0.71	-0.71	-0.74	-0.51	-0.02	0.99	0.37	0.72	0.46	1.83	-1.56	-0.69	-0.04
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	-0.72	-0.71	-0.74	-0.50	-0.02	0.99	0.38	0.72	0.47	1.84	-1.56	-0.69	-0.04
EPS in Rs	-0.70	-0.69	-0.72	-0.49	-0.02	0.96	0.37	0.70	0.46	1.79	-1.52	-0.67	-0.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	0.00	0.00	0.76	4.36	7.64	8.42	15.21	19.54	14.46	13.20	22.00	24.98	25.90
	0.14	0.23	3.34	8.24	10.88	10.25	11.69	13.16	12.86	14.38	18.44	23.52	24.91
Operating Profit	-0.14	-0.23	-2.58	-3.88	-3.24	-1.83	3.52	6.38	1.60	-1.18	3.56	1.46	0.99
OPM %			-339.47%	-88.99%	-42.41%	-21.73%	23.14%	32.65%	11.07%	-8.94%	16.18%	5.84%	3.82%
	0.21	0.32	0.31	0.22	0.25	0.29	0.20	0.09	0.32	0.42	0.36	0.52	0.53
Interest	0.00	0.05	0.26	0.80	0.96	1.01	0.89	0.37	0.42	0.37	0.35	0.39	0.39
Depreciation	0.00	0.00	0.20	1.12	1.23	1.66	1.44	1.64	1.59	1.54	1.49	1.54	1.59
Profit before tax	0.07	0.04	-2.73	-5.58	-5.18	-4.21	1.39	4.46	-0.09	-2.67	2.08	0.05	-0.46
Tax %	57.14%	25.00%	0.00%	0.00%	0.00%	0.71%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.02	0.03	-2.72	-5.58	-5.18	-4.24	1.38	4.46	-0.09	-2.67	2.07	0.05	-0.45
EPS in Rs	0.09	0.13	-5.24	-10.75	-6.32	-4.56	1.34	4.33	-0.09	-2.59	2.01	0.05	-0.44
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	10%
3 Years:	20%
TTM:	15%

Compounded Profit Growth
10 Years:	5%
5 Years:	-49%
3 Years:	37%
TTM:	-118%

Stock Price CAGR
10 Years:	%
5 Years:	13%
3 Years:	57%
1 Year:	102%

Return on Equity
10 Years:	%
5 Years:	11%
3 Years:	-3%
Last Year:	1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.25	2.25	5.19	5.19	8.19	9.29	10.29	10.29	10.29	10.29	10.29	10.29
Reserves	1.36	1.39	0.72	-4.86	-7.93	-10.42	-6.91	-2.43	-2.47	-5.08	-3.01	-2.99
	0.00	2.62	7.29	11.36	12.52	13.80	7.01	8.85	8.24	7.71	8.13	8.25
	0.21	0.03	1.66	0.84	2.02	1.67	1.39	1.42	1.28	1.79	2.11	2.95
Total Liabilities	3.82	6.29	14.86	12.53	14.80	14.34	11.78	18.13	17.34	14.71	17.52	18.50
	0.00	0.04	7.79	7.91	8.90	8.70	7.75	9.57	8.01	6.79	6.53	7.20
CWIP	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.00
	3.82	6.25	6.82	4.62	5.90	5.64	4.03	8.56	9.33	7.92	10.86	11.30
Total Assets	3.82	6.29	14.86	12.53	14.80	14.34	11.78	18.13	17.34	14.71	17.52	18.50

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0.37	-1.29	-4.81	-3.39	-1.87	5.67	2.03	-0.01	1.05	1.88	1.45
	-0.02	-10.14	-0.77	-1.97	0.24	-0.09	-0.51	0.16	0.14	0.07	-0.80
	2.64	8.91	6.52	3.35	1.27	-2.17	-1.35	-0.94	-0.95	-0.99	-1.14
Net Cash Flow	2.25	-2.52	0.94	-2.00	-0.35	3.41	0.17	-0.79	0.24	0.95	-0.49
Free Cash Flow	-0.41	-8.41	-5.81	-3.90	-1.92	5.37	1.42	-0.15	0.79	1.71	0.75
CFO/OP	139%	50%	124%	105%	101%	161%	32%	-1%	-89%	53%	99%

Ratios

Standalone / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days		43.22	29.30	38.22	26.01	40.80	83.87	59.07	61.94	38.99	25.28
Inventory Days		312.86	103.88	45.22	51.36	51.35	46.50	58.40	62.69	50.31	56.53
Days Payable		730.00	64.58	46.84	73.37	91.60	70.91	51.10	101.70	73.00	92.06
Cash Conversion Cycle		-373.92	68.61	36.60	4.00	0.55	59.46	66.37	22.93	16.30	-10.25
Working Capital Days		-2,199.61	-5.86	-96.03	-127.01	16.32	69.30	48.72	25.16	14.10	-2.92
ROCE %	1.82%	-25.39%	-38.41%	-34.49%	-25.15%	19.77%	35.65%	2.01%	-15.87%	17.37%	2.84%

Insights

In beta

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Number of Permanent Employees
employees

xx	xx	xxx	xxx	xxx	xxx
					xx.xx

Please log in to see hidden values.

B2B Revenue Share
% of revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

9 Recently

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	18.90%	18.90%	18.72%	18.72%	18.55%	18.55%	18.39%	18.39%	18.39%	18.39%	18.39%	46.58%
	81.10%	81.10%	81.29%	81.28%	81.46%	81.46%	81.62%	81.62%	81.61%	81.61%	81.61%	53.41%
No. of Shareholders	1,406	1,351	1,512	1,695	1,706	1,593	1,741	1,770	1,755	1,784	1,769	1,620

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	52.51%	45.54%	40.15%	36.25%	36.25%	19.47%	18.72%	18.39%	18.39%	46.58%
	47.49%	54.46%	59.85%	63.75%	63.75%	80.53%	81.29%	81.62%	81.61%	53.41%
No. of Shareholders	505	524	535	535	868	1,300	1,512	1,741	1,769	1,620

Documents

Announcements

All

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports